Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

EM1021

Endometrium cancer and normal tissue array, including TNM and pathology grade, 102 cases/102 cores
Unstained: $255.00 Add to Cart
H&E (EM1021s*): $255.00 Add to Cart

Microarray Panel:Endometrial carcinoma and normal tissue microarray , containing 97 cases of endometrioid adenocarcinoma, 5 normal tissue, single core per case
Cores:102
Cases:102
Layout:13 cols × 8 rows
Core Diameter:1 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910111213
A Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute
B Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute
C Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute
D Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute
E Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute
F Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute
G Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute
H Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute
Legend: Ute - Uterus

- Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIa), - Malignant tumor (stage Ia), - Malignant tumor (stage Ib), - Malignant tumor (stage Ic), - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 68 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
A2 2 F 62 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
A3 3 F 58 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
A4 4 F 46 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
A5 5 F 35 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
A6 6 F 65 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
A7 7 F 51 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
A8 8 F 53 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
A9 9 F 55 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
A10 10 F 76 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
A11 11 F 55 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
A12 12 F 54 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
A13 13 F 40 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B1 14 F 68 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
B2 15 F 62 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
B3 16 F 55 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
B4 17 F 42 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
B5 18 F 60 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B6 19 F 41 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
B7 20 F 51 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B8 21 F 45 Uterus Endometrioid adenocarcinoma 2 Ia T1aN0M0 Malignant
B9 22 F 52 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B10 23 F 58 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
B11 24 F 31 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
B12 25 F 66 Uterus Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
B13 26 F 51 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
C1 27 F 56 Uterus Endometrioid adenocarcinoma 2–3 Ia T1aN0M0 Malignant
C2 28 F 61 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
C3 29 F 72 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C4 30 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C5 31 F 50 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C6 32 F 64 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C7 33 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C8 34 F 63 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C9 35 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C10 36 F 60 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C11 37 F 62 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C12 38 F 58 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
C13 39 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D1 40 F 70 Uterus Endometrioid adenocarcinoma 2 IIIa T3aN0M0 Malignant
D2 41 F 55 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
D3 42 F 63 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D4 43 F 58 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D5 44 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D6 45 F 74 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
D7 46 F 54 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D8 47 F 74 Uterus Endometrioid adenocarcinoma (smooth muscle tissue) – Ib T1bN0M0 Malignant
D9 48 F 58 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D10 49 F 50 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D11 50 F 60 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
D12 51 F 51 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
D13 52 F 36 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E1 53 F 64 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E2 54 F 49 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
E3 55 F 71 Uterus Endometrioid adenocarcinoma 1 Ic T1cN0M0 Malignant
E4 56 F 52 Uterus Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
E5 57 F 66 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E6 58 F 60 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E7 59 F 40 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E8 60 F 53 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E9 61 F 49 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E10 62 F 56 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
E11 63 F 60 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
E12 64 F 56 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
E13 65 F 62 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
F1 66 F 67 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
F2 67 F 57 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
F3 68 F 64 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
F4 69 F 58 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
F5 70 F 65 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
F6 71 F 46 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
F7 72 F 64 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
F8 73 F 56 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
F9 74 F 56 Uterus Endometrioid adenocarcinoma 2 Ib T1bN0M0 Malignant
F10 75 F 53 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
F11 76 F 74 Uterus Endometrioid adenocarcinoma 2 II T2N0M0 Malignant
F12 77 F 53 Uterus Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
F13 78 F 47 Uterus Endometrioid adenocarcinoma (smooth muscle tissue) – Ic T1cN0M0 Malignant
G1 79 F 55 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
G2 80 F 56 Uterus Endometrioid adenocarcinoma (smooth muscle and blood vessel) – IIa T2aN0M0 Malignant
G3 81 F 58 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
G4 82 F 53 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
G5 83 F 56 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
G6 84 F 55 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
G7 85 F 46 Uterus Endometrioid adenocarcinoma 3 IIa T2bN0M0 Malignant
G8 86 F 60 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
G9 87 F 48 Uterus Endometrioid adenocarcinoma 3 II T2N0M0 Malignant
G10 88 F 61 Uterus Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
G11 89 F 78 Uterus Endometrioid adenocarcinoma 3 IIIa T3aN0M0 Malignant
G12 90 F 44 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
G13 91 F 48 Uterus Endometrioid adenocarcinoma 3 III T3N0M0 Malignant
H1 92 F 58 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
H2 93 F 33 Uterus Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
H3 94 F 39 Uterus Endometrioid adenocarcinoma (chronic inflammation of fibrous tissue) – Ia T1aN0M0 Malignant
H4 95 F 61 Uterus Endometrioid adenocarcinoma with squamous metaplasia 2 Ib T1bN0M0 Malignant
H5 96 F 64 Uterus Endometrioid adenocarcinoma with squamous metaplasia 2 Ib T1bN0M0 Malignant
H6 97 F 62 Uterus Endometrioid adenocarcinoma with squamous metaplasia 2 Ic T1cN0M0 Malignant
H7 98 F 21 Uterus Normal endometrial tissue – – – Normal
H8 99 F 18 Uterus Normal endometrial tissue – – – Normal
H9 100 F 21 Uterus Normal endometrial tissue – – – Normal
H10 101 F 18 Uterus Normal endometrial tissue – – – Normal
H11 102 F 41 Uterus Normal endometrial tissue – – – Normal

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal